News | Cardiovascular Business | December 27, 2022

CAROL Act to Expand Research Funding, Raise Awareness for Valvular Heart Disease

Photo by: Congressman Andy Barr

December 27, 2022 — President Joe Biden signed into law the Cardiovascular Advances in Research and Opportunities Legacy (CAROL) Act, legislation introduced by Representative Andy Barr (R-KY) last year to honor the legacy of his wife, Carol Leavell Barr, who passed away in 2020 from sudden cardiac death brought on by mitral valve prolapse, an underlying heart condition that is fatal in .2% of cases.

The Society of Cardiovascular Computed Tomography (SCCT) joined over 20 other organizations including the American Heart Association and the Caregiver Action Network endorsing the bill, which provides $28 million to expand research on valvular heart disease and its treatment through the National Heart, Lung, and Blood Institute.

The legislation – which passed both the U.S. Senate and House of Representatives by unanimous vote this month – outlines efforts to take action based on research findings, including identifying and disseminating best practices for relevant health care providers and raising awareness of sudden cardiac death as a result of valvular heart diseases through prevention activities.

In a letter earlier this year to Senate Health, Education, Labor and Pensions Committee Chair Sen. Patty Murray (D-WA), the supporting societies emphasized the benefits of the legislation, including funding for life-saving research on heart valve disease; increasing efforts for screening, detection, and diagnosis of heart valve disease; and expanding the out-of-hospital cardiac arrest registry data collection, Cardiac Arrest Registry to Enhance Survival (CARES).

“This bill will fund critical breakthroughs in our understanding of valvular heart disease, improve our knowledge of this poorly understood condition, and someday produce a cure,” said Congresswoman Kathleen Rice (D-NY), lead cosponsor of the CAROL Act, in an earlier statement. “I commend Rep. Barr and his family for their incredible strength and for turning grief into action.”

Along with SCCT, the CAROL Act was endorsed by Adult Congenital Heart Association; Alliance for Aging Research; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Cardiology; American College of Emergency Physicians; American Heart Association; Association of Black Cardiologists; CardioVisual; Caregiver Action Network; Children's Cardiomyopathy Foundation (CCF); HealthyWomen; Heart Valve Voice US; Hypertrophic Cardiomyopathy Association; Medical Management Associates, Inc.; Preventive Cardiovascular Nurses Association; Society for Cardiovascular Angiography and Interventions; Society for Women's Health Research; StopAfib.org/American Foundation for Women's Health; Sustainable Cardiovascular Health Equity Development Alliance; The Marfan Foundation; The Mended Hearts. Inc.; Women First Research Coalition; and WomenHeart: The National Coalition for Women with Heart Disease.

For more information: www.scct.org 

Related content: CAROL Act Will Prioritize Research on Heart Valve Disease

 


Related Content

News | Cardiovascular Business

July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing ...

Home July 29, 2024
Home
News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
Subscribe Now